Jonathan Chernoff, MD, PhD
Topics in This Section
- Executive Leadership
- Verdi DiSesa, MD, MBA
- Richard I. Fisher, MD
- Judith Lynn Bachman, RN, BSN, MSN, CNAA
- J. Robert Beck, MD
- Jeff Boyd, PhD
- Michael J. Burton
- Jonathan Chernoff, MD, PhD
- Joanne Hambleton, RN, MSN, NE-BC
- Anne Jadwin, RN, MSN, AOCN,NE-BC
- Mark L. Sobczak, MD
- Medical Leadership
- Scientific Leadership
- Senior Vice President
- Chief Scientific Officer
- Stanley P. Reimann Chair in Oncology Research
As Chief Scientific Officer, Dr. Chernoff coordinates and charts the future course of research at Fox Chase.
Jonathan Chernoff, MD, PhD, brings a wealth of institutional experience, a broad range of scientific expertise, and strong leadership skills to support and advise Dr. Boyd in all aspects of operational and strategic decision making.
In recognition of his national reputation in molecular oncology and biochemistry, Dr. Chernoff also holds the Stanley P. Reimann Chair in Oncology.
Chernoff joined the staff in 1991 as an associate member and was promoted to member with tenure in 1996. In 2002 he was promoted to be a senior member in Fox Chase Cancer Center's Basic Science division, the equivalent of a full professor in a university.
A molecular oncologist as well as a board-certified medical oncologist,
Chernoff has a special interest in factors that control cell growth and
movement, including oncogenes and anticancer or tumor-suppressor genes, and has made fundamental contributions in this research.
Chernoff earned his MD and his PhD in biochemistry in 1984 at Mount Sinai School of Medicine in New York City. He completed his residency in internal medicine at the University Health Center of Pittsburgh, a clinical fellowship in medical oncology at Johns Hopkins Oncology Center and a clinical fellowship in hematology at Beth Israel Hospital in Boston. He then held a postdoctoral fellowship in cellular and developmental biology at Harvard University before coming to Fox Chase.